Trial Details

COMPLETED
Basic Information
Clinical ID c4012
Identifier NCT01181765
Trial Title The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions BIOLOGICAL: Infliximab 5 mg/kg body weight infused over 2 hours
Participant Information
Sponsor Janssen Inc.
City Ontario
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2012-06
Primary Completion Date 2013-01
Completion Date 2013-01